Brief Summary

The study aimed at comparing the evolution of renal function in patients showing a hypertension treated by various therapeutic strategies. Due to the contract research organisation (CRO) decision in September 2000, the database was locked and not accessible for Boehringer Ingelheim France. Consequently it was decided to stop the study and not proceed to the analysis. Thus, only safety data were processed in the safety database.

Trial Health

At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment

5,417

participants targeted

Target at P75+ for all trials

Status

terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 1998

Completed

2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2000

Completed

14 years until next milestone

First Submitted

Initial submission to the registry

August 28, 2014

Completed

19 days until next milestone

First Posted

Study publicly available on registry

September 16, 2014

Completed

Last Updated

September 16, 2014

Status Verified

September 1, 2014

Enrollment Period

2.3 years

First QC Date

August 28, 2014

Last Update Submit

September 15, 2014

Conditions

Hypertension

Outcome Measures

Primary Outcomes (1)

Number of patients with adverse events
up to two years

Study Arms (1)

hypertension treatment strategies

Drug: LacidipineDrug: DiureticsDrug: antihypertensive drugsDrug: alpha blockersDrug: Angiotensin-Converting Enzyme InhibitorsDrug: beta blockers